{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:43:44Z","timestamp":1781167424107,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Infection with cytomegalovirus (CMV) is highly prevalent worldwide and can cause severe disease in immunocompromised persons and congenitally infected infants. The disease burden caused by congenital CMV infection is high, especially in resource-limited countries. Vaccines are currently under development for various target groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We evaluated the impact of vaccination strategies and hygiene intervention using transmission models. Model parameters were estimated from a cross-sectional serological population study (<jats:italic>n<\/jats:italic>=5179) and a retrospective birth cohort (<jats:italic>n<\/jats:italic>=31,484), providing information on the age- and sex-specific CMV prevalence and on the birth prevalence of congenital CMV (cCMV).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The analyses show that vertical transmission and infectious reactivation are the main drivers of transmission. Vaccination strategies aimed at reducing transmission from mother to child (vaccinating pregnant women or women of reproductive age) can yield substantial reductions of cCMV in 20 years (31.7\u201371.4% if 70% of women are effectively vaccinated). Alternatively, hygiene intervention aimed at preventing CMV infection and re-infection of women of reproductive age from young children is expected to reduce cCMV by less than 2%. The effects of large-scale vaccination on CMV prevalence can be substantial, owing to the moderate transmissibility of CMV at the population level. However, as CMV causes lifelong infection, the timescale on which reductions in CMV prevalence are expected is in the order of several decades. Elimination of CMV infection in the long run is only feasible for a vaccine with a long duration of protection and high vaccination coverage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Vaccination is an effective intervention to reduce the birth prevalence of cCMV. Population-level reductions in CMV prevalence can only be achieved on a long timescale. Our results stress the value of vaccinating pregnant women and women of childbearing age and provide support for the development of CMV vaccines and early planning of vaccination scenarios and rollouts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-020-01629-3","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T01:23:38Z","timestamp":1593653018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Short- and long-term impact of vaccination against cytomegalovirus: a modeling study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-7359","authenticated-orcid":false,"given":"Ganna","family":"Rozhnova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"E. Kretzschmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"van Baarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Korndewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"C. Vossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"4","key":"1629_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/rmv.655","volume":"20","author":"MJ Cannon","year":"2010","unstructured":"Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010; 20(4):202\u201313.","journal-title":"Rev Med Virol"},{"issue":"5","key":"1629_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/rmv.544","volume":"17","author":"SC Dollard","year":"2007","unstructured":"Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007; 17(5):355\u201363.","journal-title":"Rev Med Virol"},{"issue":"1","key":"1629_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","volume":"26","author":"S Manicklal","year":"2013","unstructured":"Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The \u201csilent\u201d global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013; 26(1):86\u2013102.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"1629_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","volume":"45","author":"P Ramanan","year":"2013","unstructured":"Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013; 45(3):260\u201371.","journal-title":"Infect Chemother"},{"issue":"1","key":"1629_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","volume":"7","author":"J Styczynski","year":"2018","unstructured":"Styczynski J. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018; 7(1):1\u201316.","journal-title":"Infect Dis Ther"},{"issue":"12","key":"1629_CR6","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/infdis\/jis620","volume":"206","author":"E Gkrania-Klotsas","year":"2012","unstructured":"Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ. Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis. 2012; 206(12):1897\u2013903.","journal-title":"J Infect Dis"},{"key":"1629_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exger.2013.11.010","volume":"54","author":"G Pawelec","year":"2014","unstructured":"Pawelec G. Immunosenenescence: role of cytomegalovirus. Exp Gerontol. 2014; 54:1\u20135.","journal-title":"Exp Gerontol"},{"issue":"6","key":"1629_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nri.2016.38","volume":"16","author":"P Klenerman","year":"2016","unstructured":"Klenerman P, Oxenius A. T cell responses to cytomegalovirus. Nat Rev Immunol. 2016; 16(6):367\u201377.","journal-title":"Nat Rev Immunol"},{"key":"1629_CR9","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2017.00784","volume":"8","author":"S Merani","year":"2017","unstructured":"Merani S, Pawelec G, Kuchel GA, McElhaney JE. Impact of aging and cytomegalovirus on immunological response to influenza vaccination and infection. Front Immunol. 2017; 8:784.","journal-title":"Front Immunol"},{"key":"1629_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1473-3099(12)70197-4","volume":"12","author":"PD Griffiths","year":"2012","unstructured":"Griffiths PD. Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation. Lancet Infect Dis. 2012; 12:790\u201398.","journal-title":"Lancet Infect Dis"},{"key":"1629_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2013.12.010","volume":"22","author":"TM Lanzieri","year":"2014","unstructured":"Lanzieri TM, Dollard SC, Bialek SR, Grosse SD. Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis. 2014; 22:44\u20138. https:\/\/doi.org\/10.1016\/j.ijid.2013.12.010.","journal-title":"Int J Infect Dis"},{"issue":"9","key":"1629_CR12","first-page":"1","volume":"14","author":"HH Ludwig A","year":"2009","unstructured":"Ludwig A HH. Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Euro Surveill. 2009; 14(9):1\u20137.","journal-title":"Euro Surveill"},{"issue":"4","key":"1629_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/cid\/cix344","volume":"65","author":"GSA Smit","year":"2017","unstructured":"Smit GSA, Padalko E, Van Acker J, Hens N, Dorny P, Speybroeck N, Devleesschauwer B. Public health impact of congenital toxoplasmosis and cytomegalovirus infection in Belgium, 2013: a systematic review and data synthesis. Clin Infect Dis. 2017; 65(4):661\u20138. http:\/\/oup.prod.sis.lan\/cid\/article-pdf\/65\/4\/661\/19378691\/cix344.pdf\nhttps:\/\/doi.org\/10.1093\/cid\/cix344.","journal-title":"Clin Infect Dis"},{"key":"1629_CR14","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMra050700","volume":"354","author":"C Morton","year":"2006","unstructured":"Morton C, Nance W. Newborn hearing screening \u2014 a silent revolution. N Engl J Medl. 2006; 354:2151\u201364.","journal-title":"N Engl J Medl"},{"issue":"9","key":"1629_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1086\/508173","volume":"43","author":"SA Staras","year":"2006","unstructured":"Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis. 2006; 43(9):1143\u201351.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1629_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jcv.2008.07.012","volume":"43","author":"SA Staras","year":"2008","unstructured":"Staras SA, Flanders WD, Dollard SC, Pass RF, McGowan JE, Cannon MJ. Cytomegalovirus seroprevalence and childhood sources of infection: a population-based study among pre-adolescents in the United States. J Clin Virol. 2008; 43(3):266\u201371.","journal-title":"J Clin Virol"},{"issue":"11","key":"1629_CR17","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1086\/652438","volume":"50","author":"SL Bate","year":"2010","unstructured":"Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis. 2010; 50(11):1439\u201347.","journal-title":"Clin Infect Dis"},{"key":"1629_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.vaccine.2012.10.074","volume":"31 Suppl 2","author":"P Griffiths","year":"2013","unstructured":"Griffiths P, Plotkin S, Mocarski E, Pass R, Schleiss M, Krause P, Bialek S. Desirability and feasibility of a vaccine against cytomegalovirus. Vaccine. 2013; 31 Suppl 2:197\u2013203.","journal-title":"Vaccine"},{"key":"1629_CR19","doi-asserted-by":"crossref","unstructured":"Bernstein DI. Congenital cytomegalovirus: a \u201cnow\u201d problem-no really. Now Clin Vaccine Immunol. 2017; 24(1).","DOI":"10.1128\/CVI.00491-16"},{"key":"1629_CR20","doi-asserted-by":"crossref","unstructured":"Schleiss MR, Permar SR, Plotkin SA. Progress toward development of a vaccine against congenital cytomegalovirus infection. Clin Vaccine Immunol. 2017; 24(12). https:\/\/doi.org\/10.1128\/CVI.00268-17 https:\/\/cvi.asm.org\/content\/24\/12\/e00268-17.full.pdf.","DOI":"10.1128\/CVI.00268-17"},{"issue":"2","key":"1629_CR21","doi-asserted-by":"publisher","first-page":"1005355","DOI":"10.1371\/journal.ppat.1005355","volume":"12","author":"KM Bialas","year":"2016","unstructured":"Bialas KM, Permar SR. The march towards a vaccine for congenital CMV: rationale and models. PLoS Pathog. 2016; 12(2):1005355.","journal-title":"PLoS Pathog"},{"key":"1629_CR22","doi-asserted-by":"publisher","unstructured":"Plotkin SA, Boppana SB. Vaccination against the human cytomegalovirus. Vaccine. 2018. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.089.","DOI":"10.1016\/j.vaccine.2018.02.089"},{"issue":"3","key":"1629_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00006454-199603000-00013","volume":"15","author":"S Adler","year":"1996","unstructured":"Adler S, Finney J, Manganello A, Best A. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr Infect Dis J. 1996; 15(3):240\u20136. https:\/\/doi.org\/10.1097\/00006454-199603000-00013.","journal-title":"Pediatr Infect Dis J"},{"key":"1629_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jcv.2009.09.003","volume":"46","author":"C Vauloup-Fellous","year":"2009","unstructured":"Vauloup-Fellous C, Picone O, Cordier A-G, Parent-du-Ch\u00e2telet I, Senat M-V, Frydman R, Grangeot-Keros L. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy?: results of a 3-year prospective study in a french hospital. J Clin Virol. 2009; 46:49\u201353. https:\/\/doi.org\/10.1016\/j.jcv.2009.09.003.","journal-title":"J Clin Virol"},{"issue":"Suppl 4","key":"1629_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/cid\/cit585","volume":"57","author":"SP Adler","year":"2013","unstructured":"Adler SP, Nigro G. Prevention of maternal-fetal transmission of cytomegalovirus. Cli Infect Dis. 2013; 57(Suppl 4):189\u201392. https:\/\/doi.org\/10.1093\/cid\/cit585. http:\/\/oup.prod.sis.lan\/cid\/article-pdf\/57\/suppl_4\/S189\/20911485\/cit585.pdf.","journal-title":"Cli Infect Dis"},{"issue":"9","key":"1629_CR26","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.ebiom.2015.08.003","volume":"2","author":"MG Revello","year":"2015","unstructured":"Revello MG, Tibaldi C, Masuelli G, Frisina V, Sacchi A, Furione M, Arossa A, Spinillo A, Klersy C, Ceccarelli M, Gerna G, Todros T. Prevention of primary cytomegalovirus infection in pregnancy. EBioMedicine. 2015; 2(9):1205\u201310. https:\/\/doi.org\/10.1016\/j.ebiom.2015.08.003.","journal-title":"EBioMedicine"},{"issue":"4","key":"1629_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/rmv.695","volume":"21","author":"MJ Cannon","year":"2011","unstructured":"Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011; 21(4):240\u201355.","journal-title":"Rev Med Virol"},{"issue":"4","key":"1629_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/rmv.535","volume":"17","author":"A Kenneson","year":"2007","unstructured":"Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007; 17(4):253\u201376.","journal-title":"Rev Med Virol"},{"key":"1629_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jpids\/piu069","volume":"3 Suppl 1","author":"RF Pass","year":"2014","unstructured":"Pass RF, Anderson B. Mother-to-child transmission of cytomegalovirus and prevention of congenital infection. J Pediatric Infect Dis Soc. 2014; 3 Suppl 1:2\u20136.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"9255","key":"1629_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0140-6736(00)04043-5","volume":"357","author":"K Hamprecht","year":"2001","unstructured":"Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 2001; 357(9255):513\u20138.","journal-title":"Lancet"},{"issue":"4","key":"1629_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2352-4642(19)30024-0","volume":"3","author":"AJ Prendergast","year":"2019","unstructured":"Prendergast AJ, Goga AE, Waitt C, Gessain A, Taylor GP, Rollins N, Abrams EJ, Lyall EH, de Perre PV. Transmission of CMV, HTLV-1, and HIV through breastmilk. Lancet Child Adolesc Health. 2019; 3(4):264\u201373.","journal-title":"Lancet Child Adolesc Health"},{"key":"1629_CR32","volume-title":"Human herpesviruses: biology, therapy, and immunoprophylaxis","author":"SB Boppana","year":"2007","unstructured":"Boppana SB, Fowler KB. Persistence in the population: epidemiology and transmisson In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press: 2007."},{"key":"1629_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcv.2014.11.033","volume":"63","author":"MJ Korndewal","year":"2015","unstructured":"Korndewal MJ, Mollema L, Tcherniaeva I, van der Klis F, Kroes ACM, Oudesluys-Murphy AM, Vossen ACTM, de Melker HE. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015; 63:53\u201358. https:\/\/doi.org\/10.1016\/j.jcv.2014.11.033.","journal-title":"J Clin Virol"},{"issue":"7","key":"1629_CR34","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1017\/S0950268815002708","volume":"144","author":"MJ Korndewal","year":"2016","unstructured":"Korndewal MJ, Vossen ACTM, Cremer J, van Binnendijk RS, Kroes ACM, van der Sande MAB, Oudesluys-Murphy AM, de Melker HE. Disease burden of congenital cytomegalovirus infection at school entry age: study design, participation rate and birth prevalence. Epidemiol Infect. 2016; 144(7):1520\u20137. https:\/\/doi.org\/10.1017\/S0950268815002708.","journal-title":"Epidemiol Infect"},{"issue":"27","key":"1629_CR35","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1016\/j.vaccine.2012.04.011","volume":"30","author":"AF Dempsey","year":"2012","unstructured":"Dempsey AF, Pangborn HM, Prosser LA. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus. Vaccine. 2012; 30(27):4060\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.011.","journal-title":"Vaccine"},{"issue":"10","key":"1629_CR36","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.vaccine.2018.01.042","volume":"36","author":"DS N\u2019Diaye","year":"2018","unstructured":"N\u2019Diaye DS, Launay O, Picone O, Tsatsaris V, Azria E, Rozenberg F, Schwarzinger M, Yazdanpanah Y. Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France. Vaccine. 2018; 36(10):1285\u201396. https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.042.","journal-title":"Vaccine"},{"issue":"11","key":"1629_CR37","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/S0264-410X(00)00377-7","volume":"19","author":"PD Griffiths","year":"2001","unstructured":"Griffiths PD, McLean A, Emery VC. Encouraging prospects for immunisation against primary cytomegalovirus infection. Vaccine. 2001; 19(11):1356\u201362. https:\/\/doi.org\/10.1016\/S0264-410X(00)00377-7.","journal-title":"Vaccine"},{"issue":"30","key":"1629_CR38","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1016\/j.vaccine.2014.05.014","volume":"32","author":"TM Lanzieri","year":"2014","unstructured":"Lanzieri TM, Bialek SR, Ortega-Sanchez IR, Gambhir M. Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection. Vaccine. 2014; 32(30):3780\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.014.","journal-title":"Vaccine"},{"issue":"7","key":"1629_CR39","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1080\/21645515.2015.1016665","volume":"11","author":"C Hogea","year":"2015","unstructured":"Hogea C, Dieussaert I, Effelterre TV, Guignard A, Mols J. A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: potential impact of vaccination strategies on congenital infection. Hum Vaccines Immunotherapeutics. 2015; 11(7):1788\u2013802. https:\/\/doi.org\/10.1080\/21645515.2015.1016665. PMID: 25984886.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"2","key":"1629_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.vaccine.2015.11.039","volume":"34","author":"JA Alfaro-Murillo","year":"2016","unstructured":"Alfaro-Murillo JA, Townsend JP, Galvani AP. Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US. Vaccine. 2016; 34(2):225\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2015.11.039.","journal-title":"Vaccine"},{"issue":"9","key":"1629_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1005719","volume":"13","author":"M van Boven","year":"2017","unstructured":"van Boven M, van de Kassteele J, Korndewal MJ, van Dorp CH, Kretzschmar M, van der Klis F, de Melker HE, Vossen AC, van Baarle D. Infectious reactivation of cytomegalovirus explaining age- and sex-specific patterns of seroprevalence. PLoS Comput Biol. 2017; 13(9):1\u201318. https:\/\/doi.org\/10.1371\/journal.pcbi.1005719.","journal-title":"PLoS Comput Biol"},{"key":"1629_CR42","doi-asserted-by":"publisher","unstructured":"Korndewal MJ, Oudesluys-Murphy AM, Kroes ACM, van der Sande MAB, de Melker HE, Vossen ACTM. Long-term impairment attributable to congenital cytomegalovirus infection: a retrospective cohort study. 1261\u20131268; 59(12). https:\/\/doi.org\/10.1111\/dmcn.13556.","DOI":"10.1111\/dmcn.13556"},{"key":"1629_CR43","first-page":"301","volume":"67","author":"FR van der Klis","year":"2009","unstructured":"van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009; 67:301\u20138.","journal-title":"Neth J Med"},{"key":"1629_CR44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1214\/16-AOAS1006","volume":"11","author":"J van de Kassteele","year":"2017","unstructured":"van de Kassteele J, van Eijkeren J, Wallinga J. Efficient estimation of age-specific social contact rates between men and women. Ann Appl Stat. 2017; 11:320\u201339.","journal-title":"Ann Appl Stat"},{"key":"1629_CR45","doi-asserted-by":"crossref","unstructured":"Diekmann O, Heesterbeek H, Britton T. Mathematical tools for understanding infectious disease dynamics: Princeton University Press; 2013.","DOI":"10.1515\/9781400845620"},{"issue":"1","key":"1629_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v076.i01","volume":"76","author":"B Carpenter","year":"2017","unstructured":"Carpenter B, Gelman A, Hoffman M, Lee D, Goodrich B, Betancourt M, Brubaker M, Guo J, Li P, Riddell A. Stan: a probabilistic programming language. J Stat Softw Artic. 2017; 76(1):1\u201332. https:\/\/doi.org\/10.18637\/jss.v076.i01.","journal-title":"J Stat Softw Artic"},{"issue":"1","key":"1629_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.vaccine.2013.09.042","volume":"32","author":"PR Krause","year":"2013","unstructured":"Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA. Priorities for CMV vaccine development. Vaccine. 2013; 32(1):4\u201310. https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.042.","journal-title":"Vaccine"},{"issue":"1","key":"1629_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","volume":"180","author":"P van den Driessche","year":"2002","unstructured":"van den Driessche P, Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math Biosci. 2002; 180(1):29\u201348. https:\/\/doi.org\/10.1016\/S0025-5564(02)00108-6.","journal-title":"Math Biosci"},{"issue":"47","key":"1629_CR49","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1098\/rsif.2009.0386","volume":"7","author":"O Diekmann","year":"2010","unstructured":"Diekmann O, Heesterbeek JAP, Roberts MG. The construction of next-generation matrices for compartmental epidemic models. J R Soc Interface. 2010; 7(47):873\u201385. https:\/\/doi.org\/10.1098\/rsif.2009.0386 http:\/\/arxiv.org\/abs\/https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsif.2009.0386.","journal-title":"J R Soc Interface"},{"issue":"4","key":"1629_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0153106","volume":"11","author":"A van Lier","year":"2016","unstructured":"van Lier A, McDonald SA, Bouwknegt M, group E, Kretzschmar ME, Havelaar AH, Mangen M-JJ, Wallinga J, de Melker HE. Disease burden of 32 infectious diseases in the Netherlands, 2007-2011. PLOS ONE. 2016; 11(4):1\u201325. https:\/\/doi.org\/10.1371\/journal.pone.0153106.","journal-title":"PLOS ONE"},{"key":"1629_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.exger.2014.03.020","volume":"55","author":"P Sansoni","year":"2014","unstructured":"Sansoni P, Vescovini R, Fagnoni FF, Akbar A, Arens R, Chiu YL, C\u0306ic\u0306in-S\u0306ain L, Dechanet-Merville J, Derhovanessian E, Ferrando-Martinez S, Franceschi C, Frasca D, Fulop T, Furman D, Gkrania-Klotsas E, Goodrum F, Grubeck-Loebenstein B, Hurme M, Kern F, Lilleri D, Lopez-Botet M, Maier AB, Marandu T, Marchant A, Mathei C, Moss P, Muntasell A, Remmerswaal EB, Riddell NE, Rothe K, Sauce D, Shin EC, Simanek AM, Smithey MJ, Soderberg-Naucler C, Solana R, Thomas PG, van Lier R, Pawelec G, Nikolich-Zugich J. New advances in CMV and immunosenescence. Exp Gerontol. 2014; 55:54\u201362.","journal-title":"Exp Gerontol"},{"issue":"5","key":"1629_CR52","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1073\/pnas.1617959114","volume":"114","author":"CF de Bourcy","year":"2017","unstructured":"de Bourcy CF, Angel CJ, Vollmers C, Dekker CL, Davis MM, Quake SR. Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging. Proc Natl Acad Sci U S A. 2017; 114(5):1105\u201310.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-020-01629-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01629-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:21:58Z","timestamp":1625181718000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01629-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1629"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01629-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"9 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The serological study (Pienter2) was approved by the Medical Ethics Testing Committee of the foundation of therapeutic evaluation of medicines (METC-STEG) in Almere, the Netherlands (clinical trial number: ISRCTN 20164309). All participants or their legal representatives had given written informed consent. The retrospective birth cohort study (CROCUS) was approved by the ethical committee of the Leiden University Medical Center in Leiden and is registered in the Dutch Trial Register under NTR3582.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}